Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa
Journal article published in 2019 by
Shaundra Eichstadt,
Melissa Barriga,
Anusha Ponakala,
Claudia Teng,
Ngon T. Nguyen,
Zurab Siprashvili,
Jaron Nazaroff,
Emily S. Gorell,
Albert S. Chiou,
Lisa Taylor,
Phuong Khuu,
Douglas R. Keene,
Kerri Rieger 
,
Rohit K. Khosla,
Louise K. Furukawa
and other authors.
,
Rohit K. Khosla,
Louise K. Furukawa
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 